FlatWing Won't Get $690K Atty Fees In Pfizer Unit Patent Fight
A Delaware federal judge on Monday denied a bid by two firms representing FlatWing Pharmaceuticals LLC to have Pfizer unit Anacor Pharmaceuticals Inc. reimburse roughly $690,000 in attorney fees that FlatWing...To view the full article, register now.
Already a subscriber? Click here to view full article